Documented judgements (PASS / HOLD / FAIL), issued in writing.
Evidence-scoped · Scope-limited · Confidential
Submit evidence for a scope-limited private review.
We confirm scope and issue a fixed quote before work begins.
Fixed fee confirmed before work begins · Confidential · Scope-limited
How Judgement Works
1)Scope confirmed — We agree on what this record will cover first.
2)Standards applied — We assess the product against pre-published standards.
3)Evidence reviewed — We review documentation and data within scope.
4)Judgement issued — PASS / HOLD / FAIL, issued in writing with reasons and an evidence log.
What You Receive
A written judgement record (PASS / HOLD / FAIL), including:
- Evidence Index (Provided / Missing / Risk flags / Next request)
- Scope statement + evidence log (minimum basis referenced)
- Required fixes for re-issue (if HOLD / FAIL)
- Resubmission path (what to provide next)
Scope (What we review)
Judgements are issued only within a defined scope, based on submitted evidence. Typical scope may include:
Claim discipline (claims mapped to supporting evidence)
High-level market alignment (e.g., EU entry readiness signals)
Ingredient transparency (INCI / label alignment)
Supply documentation (manufacturer identity, batch basis, basic quality evidence)
Price stability basis (quote/invoice evidence + validity dates)
Not Included (What we do not claim)
Not legal advice.
No guarantee of regulatory approval, listing acceptance, or market performance.
A PASS is not "compliance certified" — it indicates alignment verified within the stated scope and referenced evidence.
Evidence Submission (Minimum)
Submit what you have. Gaps are documented as HOLD, not failure — and every record includes a resubmission path.
Final label (front/back) or label draft
Full INCI (and concentrations if available)
Claims list (marketing copy / key claims)
Claim substantiation (test reports, literature, internal data)
Manufacturer details (name, site, basic quality documents if available)
Price basis (invoice/quote + validity dates)
If EU market is claimed (as applicable):
Responsible Person (RP) evidence
PIF readiness documents (summary list is acceptable)
CPNP submission evidence (if already done)
Process & Timeline
Submission (scope + evidence list confirmed)
Review (standards applied; questions issued if needed)
Record issued (PASS/HOLD/FAIL with written reasoning)
Re‑issue (after changes or missing evidence is provided)
Typical timeline: 5–10 business days after complete intake (scope dependent).
For early-stage submissions, we issue an Evidence Index (Fit & Risk Screen) first — before proceeding to a full judgement.
Re‑issue Rule
A judgement applies only to the referenced evidence. Changes in formulation, label, claims, supplier, pricing, or route‑to‑market require re‑issue.
Pricing
Pricing is scoped after intake. A fixed quote is issued before review begins.
Independence & Limits
No sponsors · No affiliates · No paid placement
Client reports are private and not published by default. We do not provide legal advice — only documented judgements within the stated scope.
Sample Records (Fictional /Structure Demonstration)
The entries below are fictional/sample records to demonstrate format only.
Verdict legend
PASS — Alignment verified within scope/evidence.
HOLD — Evidence incomplete; judgement not repeatable yet.
FAIL — Baseline unmet or high-risk conditions unverified within scope.
For Brands/Manufacturers
The following records reflect a brand or manufacturer submitting evidence directly for their own product's export readiness review.
JUDGEMENT RECORD (PUBLIC) — SAMPLE PASS
Document ID: SM-JDG-SAMPLE-PASS-001
Issued: 2026-02-12 · Last Reviewed: 2026-02-12
Submitted by: Brand / Manufacturer · Market (scope): EU (template) · Category: Skincare — Serum
Minimum evidence basis reviewed: label · INCI · claims list · substantiation summary
Subject Product: Sample Serum A (50ml) Brand: Confidential (public version)
Verdict: PASS
Reason Summary (public-safe)
This record is evidence-scoped and does not assert broader compliance.
Final label + full INCI reviewed and consistent.
Minimum claim substantiation reviewed for stated cosmetic claims.
Market-alignment evidence reviewed within the stated scope.
Standards Summary (v1.0) S1 PASS · S2 PASS · S3 PASS · S4 PASS · S5 PASS
COI Statement: No ads. No sponsorship. No affiliate influence.
JUDGEMENT RECORD (PUBLIC) — SAMPLE HOLD
Document ID: SM-JDG-SAMPLE-HOLD-001
Issued: 2026-02-12 · Last Reviewed: 2026-02-12
Submitted by: Brand / Manufacturer · Market (scope): EU (template) · Category: Skincare — Cream
Minimum evidence basis reviewed: claims list · partial label draft
Subject Product: Sample Cream B (55ml) Brand: Confidential (public version)
Verdict: HOLD
Reason Summary (public-safe)
This record is evidence-scoped and does not assert non-compliance.
Final label and full INCI not attached; judgement is not repeatable yet.
EU entry documentation (RP / PIF / CPNP) not reviewed in this record.
Standards Summary (v1.0) S1 HOLD · S2 HOLD · S3 HOLD · S4 HOLD · S5 HOLD
Required for Re-issue (minimum) Final label + full INCI + (EU) RP / PIF / CPNP evidence (if EU market is claimed) + claim substantiation + price evidence.
Public Note: HOLD reflects insufficient evidence reviewed, not a failure of the product.
COI Statement: No ads. No sponsorship. No affiliate influence.
For Buyers / Distributors
The following records reflect a buyer or distributor submitting evidence on a brand they are considering for contract. Scope focuses on supply continuity, channel conflict risk, claim integrity, and pricing logic.
JUDGEMENT RECORD (PUBLIC) — SAMPLE HOLD
Document ID: SM-JDG-SAMPLE-HOLD-002
Issued: 2026-02-12 · Last Reviewed: 2026-02-12
Submitted by: Buyer / Distributor · Market (scope): EU (template) · Category: Skincare — Toner
Minimum evidence basis reviewed: price quote · channel inquiry · partial supply schedule
Subject Product: Sample Toner D (150ml) Brand: Confidential (public version)
Verdict: HOLD
Reason Summary (public-safe)
This record is evidence-scoped and does not assert non-compliance.
Supply continuity not confirmed — no manufacturer commitment or batch schedule provided.
Channel conflict risk not cleared — existing distributor agreements in the target market were not disclosed.
Price basis documented, but lead time evidence was not provided.
Standards Summary (v1.0) S1 PASS · S2 HOLD · S3 PASS · S4 HOLD · S5 HOLD
Required for Re-issue (minimum) Manufacturer supply commitment or batch schedule + existing channel/distributor disclosure for target market + lead time documentation.
Public Note: HOLD reflects conditions that remained unverified at the time of review — not a rejection of the brand or product.
COI Statement: No ads. No sponsorship. No affiliate influence.
JUDGEMENT RECORD (PUBLIC) — SAMPLE FAIL
Document ID: SM-JDG-SAMPLE-FAIL-001
Issued: 2026-02-12 · Last Reviewed: 2026-02-12
Submitted by: Buyer / Distributor · Market (scope): EU (template) · Category: Skincare — Ampoule
Minimum evidence basis reviewed: INCI (partial) · claims list (unsubstantiated)
Subject Product: Sample Ampoule C (100ml) Brand: Confidential (public version)
Verdict: FAIL
Reason Summary (public-safe)
This record is evidence-scoped and does not assert blanket non-compliance.
A baseline standard could not be met within the reviewed evidence, or high-risk conditions remain unverified.
Required minimum evidence was not provided to support repeatable judgement.
Standards Summary (v1.0) S1 FAIL · S2 HOLD · S3 HOLD · S4 HOLD · S5 HOLD
Required for Re-issue (minimum) Provide the missing/required evidence listed in the record, then resubmit for re-issue.
COI Statement: No ads. No sponsorship. No affiliate influence.
PAGE NOTICE
This page contains fictional sample records to demonstrate structure and process only. Records do not reference or evaluate real products, and do not constitute legal advice or a compliance claim. All judgements are issued solely against submitted evidence and stated scope.
POLICY
Named cases — including brand and product identities — are not published by default. Client reports are delivered privately and may not be reproduced, redistributed, or used for public marketing purposes without written permission.
No ads. No sponsorship. No affiliate influence.
Stillmark Accord Policy
페이지 공지
이 페이지의 샘플 기록은 형식과 절차를 설명하기 위한 가상 데이터입니다. 실제 제품을 참조하거나 평가하지 않으며, 법적 조언이나 규제 인증을 구성하지 않습니다. 모든 판정은 제출된 근거와 명시된 범위에만 근거하여 발행됩니다.
정책
브랜드 및 제품 명칭을 포함한 고객 사례는 기본적으로 공개되지 않습니다. 고객 보고서는 비공개로 전달되며, 서면 허가 없이 복제, 재배포 또는 공개 마케팅 목적으로 사용될 수 없습니다.
광고 없음. 협찬 없음. 제휴 수익 없음.
Stillmark Accord Policy